Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States-Reference-Cited by-同舟云学术

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States

Published:2020-01-01 Issue:1 Volume:9 Page:87-96
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Deitelzweig Steven¹²,Baker Christine L.³,Dhamane Amol D.⁴,Mardekian Jack³,Dina Oluwaseyi³,Rosenblatt Lisa⁴,Russ Cristina³,Poretta Tayla⁴,Lingohr-Smith Melissa⁵,Lin Jay⁵

Affiliation:

1. Department of Hospital Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA

2. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA

3. Pfizer, Inc, New York, NY, USA

4. Bristol-Myers Squibb, Lawrenceville, NJ, USA

5. Novosys Health, Green Brook, NJ, USA

Funder

Pfizer and Bristol-Myers Squibb

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2020.1750418

Reference26 articles.

1. Prevalence of Diagnosed Atrial Fibrillation in Adults

2. Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

3. Cost of atrial fibrillation in United States managed care organizations

4. Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

5. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA;Journal of Medical Economics;2020-10-19